Pour profiter pleinement des bienfaits des glules, suivez cette posologie simple et rgulire
Seidelmann SB, Feofanova E, Yu B, et al
Companies are developing oral GLP-1-targeting medicines for obesity in the hope of coming up with an easier-to-dose alternative to the current generation of weekly, injectable drugs led by Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) and Eli Lilly's GIP/GLP-1 agonist Zepbound (tirzepatide)
In real-world observations, individuals on GLP-1 therapies often fall below dietary benchmarks for: 3,5 Microminerals : magnesium, potassium, calcium, iron, and zinc Vitamins : D, A, E, K, B12, B1 (thiamine), and folate Macronutrients : protein and fiber Phytonutrients : including carotenoids and flavonoids Gastrointestinal effectsincluding nausea, bloating, early satiety, and evolving food aversionsfurther constrict intake variety and volume, amplifying the risk